Literature DB >> 9151794

Mechanism of impaired insulin-stimulated muscle glucose metabolism in subjects with insulin-dependent diabetes mellitus.

G W Cline1, I Magnusson, D L Rothman, K F Petersen, D Laurent, G I Shulman.   

Abstract

To determine the mechanism of impaired insulin-stimulated muscle glycogen metabolism in patients with poorly controlled insulin-dependent diabetes mellitus (IDDM), we used 13C-NMR spectroscopy to monitor the peak intensity of the C1 resonance of the glucosyl units in muscle glycogen during a 6-h hyperglycemic-hyperinsulinemic clamp using [1-(13)C]glucose-enriched infusate followed by nonenriched glucose. Under similar steady state (t = 3-6 h) plasma glucose (approximately 9.0 mM) and insulin concentrations (approximately 400 pM), nonoxidative glucose metabolism was significantly less in the IDDM subjects compared with age-weight-matched control subjects (37+/-6 vs. 73+/-11 micromol/kg of body wt per minute, P < 0.05), which could be attributed to an approximately 45% reduction in the net rate of muscle glycogen synthesis in the IDDM subjects compared with the control subjects (108+/-16 vs. 195+/-6 micromol/liter of muscle per minute, P < 0.001). Muscle glycogen turnover in the IDDM subjects was significantly less than that of the controls (16+/-4 vs. 33+/-5%, P < 0.05), indicating that a marked reduction in flux through glycogen synthase was responsible for the reduced rate of net glycogen synthesis in the IDDM subjects. 31P-NMR spectroscopy was used to determine the intramuscular concentration of glucose-6-phosphate (G-6-P) under the same hyperglycemic-hyperinsulinemic conditions. Basal G-6-P concentration was similar between the two groups (approximately 0.10 mmol/kg of muscle) but the increment in G-6-P concentration in response to the glucose-insulin infusion was approximately 50% less in the IDDM subjects compared with the control subjects (0.07+/-0.02 vs. 0.13+/-0.02 mmol/kg of muscle, P < 0.05). When nonoxidative glucose metabolic rates in the control subjects were matched to the IDDM subjects, the increment in the G-6-P concentration (0.06+/-0.02 mmol/kg of muscle) was no different than that in the IDDM subjects. Together, these data indicate that defective glucose transport/phosphorylation is the major factor responsible for the lower rate of muscle glycogen synthesis in the poorly controlled insulin-dependent diabetic subjects.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9151794      PMCID: PMC508052          DOI: 10.1172/JCI119395

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  15 in total

1.  Validation of 13C NMR measurement of human skeletal muscle glycogen by direct biochemical assay of needle biopsy samples.

Authors:  R Taylor; T B Price; D L Rothman; R G Shulman; G I Shulman
Journal:  Magn Reson Med       Date:  1992-09       Impact factor: 4.668

Review 2.  Glucose toxicity.

Authors:  L Rossetti; A Giaccari; R A DeFronzo
Journal:  Diabetes Care       Date:  1990-06       Impact factor: 19.112

3.  Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.

Authors:  G I Shulman; D L Rothman; T Jue; P Stein; R A DeFronzo; R G Shulman
Journal:  N Engl J Med       Date:  1990-01-25       Impact factor: 91.245

4.  31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus.

Authors:  D L Rothman; R G Shulman; G I Shulman
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

5.  Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance.

Authors:  S Marshall; V Bacote; R R Traxinger
Journal:  J Biol Chem       Date:  1991-03-15       Impact factor: 5.157

6.  Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity.

Authors:  A D Baron; J S Zhu; J H Zhu; H Weldon; L Maianu; W T Garvey
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

7.  Lack of in vivo insulin resistance in controlled insulin-dependent, type I, diabetic patients.

Authors:  R R Revers; O G Kolterman; J A Scarlett; R S Gray; J M Olefsky
Journal:  J Clin Endocrinol Metab       Date:  1984-02       Impact factor: 5.958

8.  Glucose clamp technique: a method for quantifying insulin secretion and resistance.

Authors:  R A DeFronzo; J D Tobin; R Andres
Journal:  Am J Physiol       Date:  1979-09

9.  Hyperglycemia decreases glucose uptake in type I diabetes.

Authors:  H Yki-Järvinen; E Helve; V A Koivisto
Journal:  Diabetes       Date:  1987-08       Impact factor: 9.461

10.  In vivo 31P NMR measurement of glucose-6-phosphate in the rat muscle after exercise.

Authors:  G Bloch; J R Chase; M J Avison; R G Shulman
Journal:  Magn Reson Med       Date:  1993-09       Impact factor: 4.668

View more
  10 in total

1.  Features of hepatic and skeletal muscle insulin resistance unique to type 1 diabetes.

Authors:  Bryan C Bergman; David Howard; Irene E Schauer; David M Maahs; Janet K Snell-Bergeon; Robert H Eckel; Leigh Perreault; Marian Rewers
Journal:  J Clin Endocrinol Metab       Date:  2012-02-22       Impact factor: 5.958

Review 2.  The interplay of autoimmunity and insulin resistance in type 1 diabetes.

Authors:  Natalie J Nokoff; Marian Rewers; Melanie Cree Green
Journal:  Discov Med       Date:  2012-02       Impact factor: 2.970

3.  Metabolic effects of insulin in a human model of ketoacidosis combining exposure to lipopolysaccharide and insulin deficiency: a randomised, controlled, crossover study in individuals with type 1 diabetes.

Authors:  Mads V Svart; Nikolaj Rittig; Ulla Kampmann; Thomas S Voss; Niels Møller; Niels Jessen
Journal:  Diabetologia       Date:  2017-04-07       Impact factor: 10.122

4.  The importance of palmitoleic acid to adipocyte insulin resistance and whole-body insulin sensitivity in type 1 diabetes.

Authors:  Bryan C Bergman; David Howard; Irene E Schauer; David M Maahs; Janet K Snell-Bergeon; Timothy W Clement; Robert H Eckel; Leigh Perreault; Marian Rewers
Journal:  J Clin Endocrinol Metab       Date:  2012-11-12       Impact factor: 5.958

Review 5.  Metabolomics-based methods for early disease diagnostics.

Authors:  G A Nagana Gowda; Shucha Zhang; Haiwei Gu; Vincent Asiago; Narasimhamurthy Shanaiah; Daniel Raftery
Journal:  Expert Rev Mol Diagn       Date:  2008-09       Impact factor: 5.225

6.  A fermented soy permeate improves the skeletal muscle glucose level without restoring the glycogen content in streptozotocin-induced diabetic rats.

Authors:  Ludivine Malardé; Sophie Vincent; Luz Lefeuvre-Orfila; Théo Efstathiou; Carole Groussard; Arlette Gratas-Delamarche
Journal:  J Med Food       Date:  2013-01-28       Impact factor: 2.786

7.  Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity.

Authors:  A Dresner; D Laurent; M Marcucci; M E Griffin; S Dufour; G W Cline; L A Slezak; D K Andersen; R S Hundal; D L Rothman; K F Petersen; G I Shulman
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

8.  Metabolic remodeling of human skeletal myocytes by cocultured adipocytes depends on the lipolytic state of the system.

Authors:  Jean-Paul Kovalik; Dorothy Slentz; Robert D Stevens; William E Kraus; Joseph A Houmard; James B Nicoll; Y Renee Lea-Currie; Karen Everingham; C Lawrence Kien; Benjamin M Buehrer; Deborah M Muoio
Journal:  Diabetes       Date:  2011-05-20       Impact factor: 9.461

9.  Integrated analysis of the gene expression profile and DNA methylation profile of obese patients with type 2 diabetes.

Authors:  Juan Shen; Bin Zhu
Journal:  Mol Med Rep       Date:  2018-03-28       Impact factor: 2.952

10.  Alterations in gastrointestinal, endocrine, and metabolic processes after bariatric Roux-en-Y gastric bypass surgery.

Authors:  Christian-Heinz Anderwald; Andrea Tura; Miriam Promintzer-Schifferl; Gerhard Prager; Marietta Stadler; Bernhard Ludvik; Harald Esterbauer; Martin Georg Bischof; Anton Luger; Giovanni Pacini; Michael Krebs
Journal:  Diabetes Care       Date:  2012-08-24       Impact factor: 19.112

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.